Radioligands containing ALB can form high-molecular-weight complexes with albumin (∼66 kDa) in blood and show prolonged clearance from the kidney, resulting in increased tumor delivery and low renal uptake (20–24). The gene discussed is ALB; the disease is neoplasm.